Who Tells the Story of the Treatment of Androgenetic Alopecia?—A Bibliometric Analysis From 2003 to 2023

ABSTRACT Background Androgenetic alopecia (AGA) is a common form of nonscarring hair loss that affects both men and women, significantly influencing psychological well‐being and quality of life. Although AGA accounts for over 90% of male hair loss, there has been limited bibliometric analysis to guide the direction of research and the development of treatments. Methods A thorough literature search was performed using the Web of Science database, resulting in the identification of 2203 articles on AGA treatment published between 2003 and 2023. The search was restricted to English‐language peer‐reviewed publications. Bibliometric analysis was conducted to assess research trends, publication growth, and key contributors in AGA treatment research. Results The United States and China emerged as the leading contributors, with major institutions such as the Mayo Clinic and Harvard Medical School making significant contributions. The research focus has shifted from traditional drug therapies to innovative treatments, such as platelet‐rich plasma (PRP), and anti‐androgen therapy. Key research areas included anti‐androgen treatments, PRP, and microneedling, whereas emerging trends pointed to stem cell therapy and gene therapy as future directions. Conclusion The bibliometric analysis of AGA treatment research demonstrates an increasing interest in novel therapies and a transition towards more personalized and effective treatment approaches. These findings provide valuable insights into the development of AGA research and underscore areas in need of further exploration, offering a strategic guide for future research and clinical practice enhancements.